Q2 2026 Recap: Dermatology News & Updates

During the second quarter of 2026, a series of notable events took place in the field of dermatology, including the release of emerging clinical data, new regulatory advancements, and the general evolution of treatment paradigms, reshaping the management of inflammatory skin diseases. Stories regarding new US Food and Drug Administration (FDA) approvals as well as promising investigational therapies and consensus recommendations shaped Q2 2026.